Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    Subscribe
    Home»Banking & Finance»AIIB Commits US$100 million in CEL Infrastructure Investment Fund II
    Banking & Finance

    AIIB Commits US$100 million in CEL Infrastructure Investment Fund II

    Marie JonesBy Marie JonesJuly 5, 2022No Comments2 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    CEL Infrastructure Investment Fund II (Fund II), a private equity fund sponsored and managed by China Everbright Limited (CEL, HKG: 165) has made significant progress in fundraising. On June 29, 2022, Asian Infrastructure Investment Bank (AIIB) approved to commit of US$100 million including up to US$25 million co-investment sleeve in Fund II. AIIB is a multilateral development bank with 105 members from all over the world. Its vision is to finance “Infrastructure for Tomorrow” with sustainability at its core. AIIB is committed to unlocking new capital and investing in green, technology-enabled and cross-border connectivity infrastructure to promote sustainable economic development and regional connectivity in Asia and around the world. This will be the first time funds managed by CEL have raised capital from a multilateral development bank, marking a new stage of internationalization, professionalization and marketization for CEL. Fund II will focus on climate finance and ESG investing, and will introduce ESG investment, management, assessment and evaluation policy with international standards in order to ensure that future investments will have real-world positive impacts on addressing climate change and improving the environment and society.

    Overseas Infrastructure Investment Fund team (the Team) is one of the major teams under CEL pursuing overseas investment. Everbright Overseas Infrastructure Investment Fund L.P. (“Fund I”), established and managed by the Team, deployed more than US$450 million in infrastructure assets in Europe, Southeast Asia and Hong Kong SAR. Fund I, now at its harvest period, has achieved outstanding performance amongst its peers with distribution to paid-in capital over 1.0x. The Team is raising Fund II with a target size of US$600 million, focusing on green and low carbon themes. Fund II will primarily invest in renewable energy, new infrastructure and logistics projects in Southeast Asia and some other Asian countries. Fund II is expected to have its first closing within 2022.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleTianyun International Awarded “Social Responsibility Model”, “Advanced Enterprise of Outstanding Contribution” and “Top 10 Enterprises (Export)” by CCFIA
    Next Article ASEAN’s most influential fintech event – WFIS, now ready to disrupt Philippines’ FSI market

    Related Posts

    HKTDC Chairman deepens Hong Kong-GCC business ties with visit to Qatar

    October 28, 2026

    AI Has No Single Answer About Your Brand: Why 43% of AI Answers Swap Leading Banks and Single Visibility Scores Fail Banking Leaders

    October 20, 2026

    Scalare Launches EquityRoom, Adding a Subscription Revenue Stream to Its Founder Ecosystem

    October 19, 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Latest News

    • HKTDC Chairman deepens Hong Kong-GCC business ties with visit to Qatar
    • The 16th Asian Logistics, Maritime and Aviation Conference takes place on 16 and 17 November
    • DataTracks Extends Pillar Two Filing Support to Australia and New Zealand
    • Formerra Adjusts Transportation Surcharge Amid Continued Freight and Logistics Pressures
    • CanSinoBIO Reports Growth in First Nine Months: Commercialization Accelerates Across Multiple Products as Platform Innovation Opens New Avenues for Growth
    • Twin lighting fairs open with some 3,000 exhibitors showcasing global lighting solutions
    • 18th Hong Kong International Wine & Spirits Fair opens next week
    • Quant Group Validates Its Physical AI Foundation Model in a Working Restaurant Kitchen
    • Australian Made puts Singaporean approval centre-stage of its new campaign launch
    • Micot Pharma Showcases First-in-Class, Brain-Penetrant TrkB Agonist MT200605 at World Stroke Congress, Building the Case for Global Partnerships and Commercialization
    © 2026 BusinessNewsAsia.com

    Type above and press Enter to search. Press Esc to cancel.